Review article: alternative approaches to the long-term management of GERD
- PMID: 16303036
- DOI: 10.1111/j.1365-2036.2005.02711.x
Review article: alternative approaches to the long-term management of GERD
Abstract
Although proton-pump inhibitors are highly effective for the treatment of gastro-oesophageal reflux disease, there are issues with long-term maintenance therapy: not all patients require full daily dose for maintenance treatment, some patients are reluctant to take long-term daily medication, and long-term PPI therapy is inadequate for some patients. This article aims to review alternatives to daily proton-pump inhibitor therapy for the long-term management of gastro-oesophageal reflux disease, including intermittent or on-demand proton-pump inhibitor use, as well as endoscopic and surgical options. On-demand proton-pump inhibitor therapy has demonstrated efficacy in achieving acceptable symptom control, healing and maintenance of quality of life for a proportion of patients with gastro-oesophageal reflux disease. Endoscopic antireflux procedures can reduce the need for proton-pump inhibitor therapy, but safety and durability of these procedures require more study. Surgical treatment of gastro-oesophageal reflux disease in properly selected patients has demonstrated efficacy in reducing symptoms and the need for proton-pump inhibitor therapy; however, long-term follow-up suggests that it is not a permanent solution for many patients. While daily proton-pump inhibitor therapy remains the main treatment regimen option for most patients with gastro-oesophageal reflux disease, on-demand therapy may prove effective for many patients. Endoscopic anti-reflux therapies and surgery are options for patients who prefer nonpharmacological treatment, but experience is limited at this point in time for the former.
Similar articles
-
Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.Aliment Pharmacol Ther. 2004 Sep 15;20(6):637-43. doi: 10.1111/j.1365-2036.2004.02127.x. Aliment Pharmacol Ther. 2004. PMID: 15352912
-
Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.Aliment Pharmacol Ther. 2006 Sep 15;24(6):945-54. doi: 10.1111/j.1365-2036.2006.03084.x. Aliment Pharmacol Ther. 2006. PMID: 16948806 Clinical Trial.
-
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.Yale J Biol Med. 1996 May-Jun;69(3):211-24. Yale J Biol Med. 1996. PMID: 9165690 Free PMC article. Review.
-
Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.J Gastroenterol Hepatol. 2007 May;22(5):639-44. doi: 10.1111/j.1440-1746.2007.04871.x. J Gastroenterol Hepatol. 2007. PMID: 17444849 Clinical Trial.
-
Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.Aliment Pharmacol Ther. 2006 Mar;23 Suppl 1:25-32. doi: 10.1111/j.1365-2036.2006.02802.x. Aliment Pharmacol Ther. 2006. PMID: 16483267 Review.
Cited by
-
Long-term Use of Proton-Pump Inhibitor Therapy.Gastroenterol Hepatol (N Y). 2008 May;4(5):322-5. Gastroenterol Hepatol (N Y). 2008. PMID: 21904505 Free PMC article. No abstract available.
-
Acid peptic diseases: pharmacological approach to treatment.Expert Rev Clin Pharmacol. 2009 May;2(3):295-314. doi: 10.1586/ecp.09.8. Expert Rev Clin Pharmacol. 2009. PMID: 21822447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical